Barclays »

Phio Pharmaceuticals Corp shares owned by Barclays

Quarter-by-quarter ownership of Phio Pharmaceuticals Corp (PHIO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Phio Pharmaceuticals Corp

Tip: Access up to 7 years of quarterly data

All positions including Phio Pharmaceuticals Corp held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phio Pharmaceuticals Corp by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $237 231 1.03
2025-03-31 $0 5 0.00
2024-12-31 $0 203 0.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Phio Pharmaceuticals Corp

Jane Street
Geode Capital Management
Vanguard Capital Management
Nomura Asset Management International
Cetera Investment Advisers
Citadel Advisors
Vanguard Fiduciary Trust
Northern Trust
Two Sigma Investments
XTX Topco
Hrt Financial
Bridgeway Capital Management
Captrust Financial Advisors
Tower Research Capital
Morgan Stanley

View all funds holding Phio Pharmaceuticals Corp